vs
Side-by-side financial comparison of Paranovus Entertainment Technology Ltd. (PAVS) and Prelude Therapeutics Inc (PRLD). Click either name above to swap in a different company.
Paranovus Entertainment Technology Ltd. is the larger business by last-quarter revenue ($12.4M vs $6.5M, roughly 1.9× Prelude Therapeutics Inc). Paranovus Entertainment Technology Ltd. runs the higher net margin — -5.5% vs -303.5%, a 298.0% gap on every dollar of revenue. On growth, Paranovus Entertainment Technology Ltd. posted the faster year-over-year revenue change (18033.4% vs 116.7%).
PAVS vs PRLD — Head-to-Head
Income Statement — Q2 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $12.4M | $6.5M |
| Net Profit | $-681.0K | $-19.7M |
| Gross Margin | 20.0% | — |
| Operating Margin | -5.1% | -314.1% |
| Net Margin | -5.5% | -303.5% |
| Revenue YoY | 18033.4% | 116.7% |
| Net Profit YoY | 61.4% | 38.9% |
| EPS (diluted) | — | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $12.4M | $6.5M | ||
| Q3 24 | — | $3.0M | ||
| Q3 23 | $0 | — |
| Q3 25 | $-681.0K | $-19.7M | ||
| Q3 24 | — | $-32.3M | ||
| Q3 23 | $8.2M | — |
| Q3 25 | 20.0% | — | ||
| Q3 24 | — | — | ||
| Q3 23 | — | — |
| Q3 25 | -5.1% | -314.1% | ||
| Q3 24 | — | -1145.9% | ||
| Q3 23 | — | — |
| Q3 25 | -5.5% | -303.5% | ||
| Q3 24 | — | -1075.7% | ||
| Q3 23 | — | — |
| Q3 25 | — | $-0.26 | ||
| Q3 24 | — | $-0.43 | ||
| Q3 23 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.2M | $55.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $23.6M | $58.5M |
| Total Assets | $37.3M | $94.8M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $5.2M | $55.0M | ||
| Q3 24 | — | $153.6M | ||
| Q3 23 | $1.0M | — |
| Q3 25 | $23.6M | $58.5M | ||
| Q3 24 | — | $156.4M | ||
| Q3 23 | $10.7M | — |
| Q3 25 | $37.3M | $94.8M | ||
| Q3 24 | — | $197.2M | ||
| Q3 23 | $11.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-159.3K | $-19.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $-159.3K | $-19.1M | ||
| Q3 24 | — | $-27.3M | ||
| Q3 23 | $-13.1M | — |
| Q3 25 | — | — | ||
| Q3 24 | — | $-27.4M | ||
| Q3 23 | — | — |
| Q3 25 | — | — | ||
| Q3 24 | — | -912.0% | ||
| Q3 23 | — | — |
| Q3 25 | — | 0.0% | ||
| Q3 24 | — | 2.1% | ||
| Q3 23 | — | — |
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q3 23 | -1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
